New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2013
05:55 EDTMDT, MDT, COV, COV, INTC, INTC, BSX, BSX, VRTX, VRTX, JNJ, JNJOpal to host a summit
4th Annual Medical Devices Summit is being held in Boston on February 28-March 1.
News For MDT;COV;INTC;BSX;VRTX;JNJ From The Last 14 Days
Check below for free stories on MDT;COV;INTC;BSX;VRTX;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 8, 2014
08:08 EDTINTCCost to Apple, Google, Intel, of 'no-poaching' deal may be high, DealBook says
Some of the of the biggest names in tech, including Apple (AAPL), Google (GOOG), Intel (INTC)and Adobe (ADBE), are at the center of a class-action suit that seeks $9B as compensation for employees who contend the tech giants colluded to prevent their employees from being hired at rivals, reported The New York Times' DealBook. Reference Link
07:26 EDTMDT, JNJ, COVElsevier Business Intelligence to hold a conference
Subscribe for More Information
April 7, 2014
18:01 EDTBSXBoston Scientific gets FDA, CE Mark clearance for Expect Slimline Needle
Boston Scientific announced it has received clearance from the U.S. FDA and CE Mark approval in Europe for the Expect Slimline Needle, which is now globally available for Endoscopic Ultrasound-Fine Needle Aspiration procedures. The Expect Slimline Needle is on contract with four leading group purchasing organizations.
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
07:58 EDTMDTMedtronic data positive for C.R. Bard, says Barclays
Barclays said Medtronic's (MDT) better than expected drug coated balloon data could have a positive class effect that benefits C.R. Bard (BCR). The firm reiterates its Overweight rating C.R. Bard and raised its price target to $165 from $160. Note that BofA/Merrill downgraded C.R. Bard to Neutral from Buy following the Medtronic's news.
07:38 EDTMDTMedtronic data should lead to approval of drug-coated balloon, says Wells Fargo
Subscribe for More Information
05:55 EDTINTCIntel upgraded to Outperform from Sector Perform at Pacific Crest
Pacific Crest upgraded its rating on Intel (INTC) shares to Outperform with a $31 price target citing improving corporate PC demand and expectations the company's Grantley server platform will drive spending at traditional IT customers in 2015. Shares of Intel closed Friday down 25c to $26.16.
April 4, 2014
16:00 EDTINTCOptions Update; April 4, 2014
iPath S&P 500 VIX Short-Term Futures up 89c to 41.88. Option volume leaders: AAPL C P NFLX LNG BAC INTC TSLA TWTR according to Track Data.
April 3, 2014
16:16 EDTINTCGlobalfoundries in lead to buy IBM chip plants, TSMC out of talks, WSJ says
IBM (IBM) has held talks with Globalfoundries, Intel (INTC) and Taiwan Semiconductor (TSM) regarding its semiconductor manufacturing operations, and Globalfoundries appears to be in the lead as the most likely potential buyer, according to The Wall Street Journal, citing people familiar with the matter. IBM initially asked for more than $2B and bids have come in "north of $1B," the report noted, adding that Intel is still involved, but TSMC has dropped out of the talks. Reference Link
16:00 EDTINTCOptions Update; April 3, 2014
Subscribe for More Information
15:49 EDTINTCGlobalfoundries in lead to buy IBM chip plants, TSMC out of talks, DJ says
IBM (IBM) also held talks with Intel (INTC), according to Dow Jones, citing sources.
10:01 EDTINTCIntel climbs following upbeat note from analyst
Subscribe for More Information
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
April 2, 2014
16:09 EDTINTCIntel upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray upgraded Intel to Overweight from Neutral after assuming coverage of the stock and raised its price target for shares to $30 from $23. Piper expects the PC market stabilization to continue in 2014 and believes Intel is positioned longer term to benefit from data center market growth.
15:00 EDTCOVCovidien management to meet with Piper Jaffray
Subscribe for More Information
09:36 EDTMDTMedtronic has a conference call hosted by JPMorgan
JPMorgan Analyst Weinstein will host a conference call with CEO Omar Ishrak on April 3 at 10 am.
08:40 EDTCOV, JNJPiper Jaffray to hold booth tours
Booth Tours at SAGES Annual Meeting will be held in Salt Lake City, Utah on April 2-3.
08:31 EDTBSX, COVSociety of American Gastrointestinal & Endoscopic Surgeons holds annual meeting
2014 Annual Meeting of SAGES is being held in Salt Lake City, Utah on April 2-5.
06:08 EDTINTCIntel setting up $100M fund for China, WSJ reports
Intel's venture capital arm will establish a $100M fund to help accelerate the creation of new devices that use its chips, the Wall Street Journal reports, citing comments made at an event for developers. The company is also setting up an innovation center in Shenzhen, China. Reference Link
05:23 EDTBSXBoston Scientific reports favorable results in MADIT-CRT study
Boston Scientific reported favorable results in studies related to cardiac resynchronization therapy, or CRT, platinum chromium stent platforms and transcatheter aortic valve replacement, or TAVR. Boston Scientific announced significant findings from the continued analysis of the landmark MADIT-CRT study, demonstrating a significant and sustained survival benefit in the indicated population. The long-term results demonstrated a 41% relative reduction in the risk of death in patients who received a Boston Scientific defibrillator with CRT compared to patients who received a defibrillator alone. In addition to the mortality benefit, the results demonstrate that these patients experienced a 62% relative reduction in the risk of experiencing a first heart failure event when compared to patients who didn't receive CRT therapy. Boston Scientific released new data that continue to reinforce the advantages of platinum chromium stents. The trial compared the safety and effectiveness of the Boston Scientific Platinum Chromium Everolimus-Eluting Stent System, or PtCr EES, to the Abbott Laboratories Cobalt Chromium Everolimus-Eluting Stent System, or CoCr EES. The results show low event rates out to four years with PtCr EES confirming excellent long-term performance. At four years, the PtCr EES also continued to demonstrate advantages over the CoCr EES. The Boston Scientific Lotus Valve System advanced TAVR technology continued to demonstrate impressive performance at three months.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use